FDA Takes News of Tysabri-Related Infections In Stride
JGrimes
The FDA said yesterday that it’s working with the makers of Tysabri to update the label of the multiple sclerosis drug. The new label will reflect two cases of a serious brain infection diagnosed a few weeks ago in patients taking the drug.
But the agency’s announcement also included language that should come as […]